We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
-1.28%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$899M
AUM Growth
-$200M
Cap. Flow
-$149M
Cap. Flow %
-16.52%
Top 10 Hldgs %
45.66%
Holding
187
New
15
Increased
24
Reduced
28
Closed
36

Top Buys

Rank Stock Value
1
HOME
At Home Group Inc.
HOME
+$16.7M
2
CDLX icon
Cardlytics
CDLX
+$8.24M
3
IMVT icon
Immunovant
IMVT
+$7.9M
4
ENVA icon
Enova International
ENVA
+$4.81M
5
QURE icon
uniQure
QURE
+$4.04M

Top Sells

Rank Stock Value
1
STNG icon
Scorpio Tankers
STNG
+$24.7M
2
COF icon
Capital One
COF
+$22.3M
3
PCG icon
PG&E
PCG
+$15.9M
4
MU icon
Micron Technology
MU
+$13.9M
5
CVNA icon
Carvana
CVNA
+$11.9M

Sector Composition

Rank Sector Weight
1 Healthcare 24.43%
2 Consumer Discretionary 19.26%
3 Communication Services 6.4%
4 Financials 4.13%
5 Energy 3.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDC
51
PUT
DELISTED
M.D.C. Holdings, Inc.
MDC
$4.31M 0.48%
108,000
-108,000
-50% -$3.79M
TWNKW
52
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
$4.31M 0.48%
2,520,000
– –
FATE icon
53
Fate Therapeutics
FATE
$286M
$3.49M 0.39%
225,000
-75,000
-25% -$1.44M
JNJ icon
54
Johnson & Johnson
JNJ
$618B
$3.23M 0.36%
+25,000
New +$3.29M
DHT icon
55
DHT Holdings
DHT
$3.02B
$3.17M 0.35%
515,000
– –
OTIC
56
DELISTED
Otonomy, Inc.
OTIC
$2.63M 0.29%
1,100,000
– –
CUE icon
57
Cue Biopharma
CUE
$115M
$2.53M 0.28%
+10,000
New +$2.4M
IRCP
58
DELISTED
IRSA Propiedades Comerciales S.A.
IRCP
$2.4M 0.27%
794,575
+94,903
+14% +$359K
AGTC
59
DELISTED
Applied Genetic Technologies Corporation
AGTC
$2.32M 0.26%
557,834
+357,834
+179% +$1.29M
TGTX icon
60
TG Therapeutics
TGTX
$7.99B
$2.25M 0.25%
400,000
-95,000
-19% -$662K
SBBP
61
DELISTED
Strongbridge Biopharma plc.
SBBP
$2.21M 0.25%
923,700
– –
MBIO icon
62
Mustang Bio
MBIO
$4.32M
$2.04M 0.23%
833
– –
ZGNX
63
DELISTED
Zogenix, Inc.
ZGNX
$2M 0.22%
50,000
– –
TNK icon
64
Teekay Tankers
TNK
$2.79B
$1.85M 0.21%
178,125
– –
AGRO icon
65
Adecoagro
AGRO
$1.43B
$1.75M 0.19%
300,000
-50,000
-14% -$315K
LRMR icon
66
Larimar Therapeutics
LRMR
$398M
$1.72M 0.19%
194,284
+83,025
+75% +$910K
MRNS
67
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.7M 0.19%
275,000
-75,000
-21% -$606K
AVEO
68
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$1.67M 0.19%
+197,872
New +$1.47M
GNK icon
69
Genco Shipping & Trading
GNK
$1.12B
$1.66M 0.18%
180,496
– –
MUDSW
70
DELISTED
Mudrick Capital Acquisition Corporation Warrant
MUDSW
$1.56M 0.17%
2,500,000
– –
PHGE icon
71
BiomX
PHGE
$1.98M
$1.39M 0.15%
721
-68
-9% -$133K
DMK
72
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$1.37M 0.15%
27,698
+15,555
+128% +$1.12M
SDRL
73
DELISTED
Seadrill Limited Common Stock
SDRL
$1.32M 0.15%
627,302
-119,649
-16% -$379K
VRDN icon
74
Viridian Therapeutics
VRDN
$2.13B
$1.29M 0.14%
117,736
– –
SRRA
75
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$1.28M 0.14%
81,874
+6,285
+8% +$120K
1 2
3
4 5

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, 683 Capital Management held 187 positions worth $899M, down 18% from $1.1B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

683 Capital Management withdrew a net $149M in Q3 2019, closing 36 positions and reducing 28 holdings. Its most notable exit was Capital One, an estimated $22.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, 683 Capital Management opened a new position in At Home Group Inc. worth $23.6M.

  • 683 Capital Management's largest Q3 2019 buy was At Home Group Inc.: 2,450,000 shares worth $23.6M.
  • 683 Capital Management added most to Cardlytics in Q3 2019, an estimated $8.24M increase.
  • 683 Capital Management's biggest Q3 2019 reduction was Scorpio Tankers, cutting an estimated $24.7M.
  • 683 Capital Management fully exited Capital One in Q3 2019, selling an estimated $22.3M.
  • 683 Capital Management's ten largest holdings make up 46% of its $899M portfolio in Q3 2019.
  • 683 Capital Management opened 15 new positions and closed 36 in Q3 2019.
  • 683 Capital Management's portfolio value fell 18% quarter-over-quarter to $899M.

Based on 683 Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.